CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,574,669 | +82.9% | 587,576 | +10.2% | 0.00% | +100.0% |
| Q1 2023 | $12,341,358 | -11.8% | 533,104 | -0.1% | 0.00% | -33.3% |
| Q4 2022 | $13,985,874 | +68.6% | 533,812 | +26.5% | 0.00% | +50.0% |
| Q3 2022 | $8,297,000 | +22.1% | 422,035 | +8.6% | 0.00% | +100.0% |
| Q2 2022 | $6,795,000 | +18.6% | 388,507 | +10.9% | 0.00% | 0.0% |
| Q1 2022 | $5,731,000 | +0.9% | 350,290 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $5,679,000 | +46.5% | 348,177 | +14.6% | 0.00% | 0.0% |
| Q3 2021 | $3,877,000 | -10.4% | 303,838 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $4,328,000 | +47.9% | 306,486 | +62.8% | 0.00% | 0.0% |
| Q1 2021 | $2,926,000 | -7.3% | 188,237 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $3,156,000 | – | 198,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |